AstraZeneca Covid jab ‘to be available by Jan’
November 21 2020 12:04 AM
crowded market
A health worker takes the temperature of shoppers at a crowded market amid the spread of the coronavirus disease, in Ahmedabad, yesterday.


The head of an Indian company contracted to make AstraZeneca’s Covid vaccine said it could deliver it to health care workers and elderly Indians by January as the country’s caseload of infections crossed 9mn yesterday.
The Serum Institute of India, the world’s largest vaccine manufacturer, has already manufactured millions of doses of the vaccine that is being developed in collaboration with Oxford University while results from late-stage trials are awaited.
Britain-based AstraZeneca has signed several supply and manufacturing deals with companies and governments around the world. 
 On Thursday, data published in the medical journal The Lancet showed that AstraZeneca’s vaccine produced a strong immune response in older adults, with researchers expecting to release late-stage trial results by Christmas.
Drugmakers Pfizer and Moderna have also released data from late-stage trials that shows more than 90% efficacy in their vaccine candidates.
India is watching the progress of the Pfizer and Moderna vaccines, but availability and supply could be an issue with a population as large as India’s, the head of a committee advising the prime minister said this week.
Adar Poonawaala, the chief executive of the SII, said that his company would seek emergency use authorisation for the AstraZeneca vaccine as soon as authorities in the UK approved it and made it available for the general public. 
 “It’s been a Herculean task and we are very happy now that we are almost now on autopilot waiting just for the vaccine results to come,” Poonawaala told a conference.”

There are no comments.

LEAVE A COMMENT Your email address will not be published. Required fields are marked*